Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8285708 | Parkinsonism & Related Disorders | 2017 | 26 Pages |
Abstract
Rotigotine was efficacious in Chinese patients with advanced-stage PD as add-on therapy to levodopa, significantly reducing “off” time vs placebo; the treatment difference was similar to that observed in previous studies of mainly Caucasian patients. Rotigotine was generally well-tolerated and had a similar AE profile to those observed in previous studies.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Zhen-Xin Zhang, Chun-Feng Liu, En-Xiang Tao, Ming Shao, Yi-Ming Liu, Jian Wang, Mahnaz Asgharnejad, Hai-Bo Xue, Erwin Surmann, Lars Bauer,